Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Peer Christiansen"'
Autor:
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen, Bent Ejlertsen
Publikováno v:
Cold, S, Cold, F, Jensen, M-B, Cronin-Fenton, D, Christiansen, P & Ejlertsen, B 2022, ' Systemic or Vaginal Hormone Therapy After Early Breast Cancer : A Danish Observational Cohort Study ', Journal of the National Cancer Institute, vol. 114, no. 10, pp. 1347-1354 . https://doi.org/10.1093/jnci/djac112
Cold, S, Cold, F, Jensen, M B, Cronin-Fenton, D, Christiansen, P & Ejlertsen, B 2022, ' Systemic or Vaginal Hormone Therapy After Early Breast Cancer : A Danish Observational Cohort Study ', Journal of the National Cancer Institute, vol. 114, no. 10, pp. 1347-1354 . https://doi.org/10.1093/jnci/djac112
Cold, S, Cold, F, Jensen, M B, Cronin-Fenton, D, Christiansen, P & Ejlertsen, B 2022, ' Systemic or Vaginal Hormone Therapy After Early Breast Cancer : A Danish Observational Cohort Study ', Journal of the National Cancer Institute, vol. 114, no. 10, pp. 1347-1354 . https://doi.org/10.1093/jnci/djac112
Background Women treated for breast cancer (BC) often suffer genitourinary syndrome of menopause. These symptoms may be alleviated by vaginal estrogen therapy (VET) or menopausal hormone therapy (MHT). However, there are concerns of risks of recurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a59925f78875291c62f7ea0371a867e
https://pure.au.dk/portal/da/publications/systemic-or-vaginal-hormone-therapy-after-early-breast-cancer(a422edc0-07cf-423c-a4d0-e87455b5d363).html
https://pure.au.dk/portal/da/publications/systemic-or-vaginal-hormone-therapy-after-early-breast-cancer(a422edc0-07cf-423c-a4d0-e87455b5d363).html
Autor:
Søren Cold, Frederik Cold, Maj-Britt Jensen, Deirdre Cronin-Fenton, Peer Christiansen, Bent Ejlertsen
Publikováno v:
Cold, S, Cold, F, Jensen, M-B, Cronin-Fenton, D, Christiansen, P & Ejlertsen, B 2023, ' Response to Pederson et al. and Chlebowski et al ', Journal of the National Cancer Institute, vol. 115, no. 2, pp. 229–230 . https://doi.org/10.1093/jnci/djac214
Autor:
Kasper Kjærgaard, Jannik Wheler, Looket Dihge, Peer Christiansen, Signe Borgquist, Deirdre Cronin-Fenton
Publikováno v:
Cancer Research. 83:P3-03
Introduction Type 2 diabetes (T2D) is associated with obesity and other comorbidities involving multiple organ systems, which may increase the risk of postsurgical complications. Knowledge is sparse on the impact of T2D on the postsurgical outcome af
Autor:
Buket Öztürk Esen, Rikke Nørgaard Pedersen, Deirdre Cronin-Fenton, Lene Mellemkjær, Timothy L. Lash, Bent Ejlertsen, Peer Christiansen, Mette Nørgaard
Publikováno v:
J Natl Cancer Inst
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Background Extended, more effective breast cancer treatments have increased the prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between pat
Autor:
Mads Thomassen, Peer Christiansen, Trine V Axelsen, Ebbe Boedtkjer, Marco Mele, Helene L Pedersen, Tonje Johansen, Mark Burton, Eva Balling, Nicolai J Toft
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbe84be00a67f928d3ce2c04baa5fba9
https://doi.org/10.7554/elife.68447.sa2
https://doi.org/10.7554/elife.68447.sa2
Autor:
M.T.F.D. Vrancken Peeters, R.A.E.M. Tollenaar, E. Heeg, M.B. Jensen, Peer Christiansen, Bent Ejlertsen, Marc A.M. Mureau
Publikováno v:
Breast Cancer Research and Treatment, 182(3), 709-718. SPRINGER
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Purpose Breast-contour preservation (BCP) is possible for most women treated for early-stage breast cancer. BCP can be defined as primary breast-conserving treatment (BCT), neoadjuvant chemotherapy (NAC) followed by BCT and immediate postmastectomy b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38648ffb3e234e8a674854b52cd34809
https://link.springer.com/article/10.1007/s10549-020-05725-z
https://link.springer.com/article/10.1007/s10549-020-05725-z
Autor:
Deirdre Cronin-Fenton, Peer Christiansen, Thomas P. Ahern, Rulla M. Tamimi, Timothy L. Lash, Sinna Pilgaard Ulrichsen, Bernard F. Cole, Anne Broe, Per Damkier, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate Exposure and Breast Cancer Incidence : A Danish Nationwide Cohort Study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate exposure and breast cancer incidence : A danish nationwide cohort study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
Ahern, T P, Broe, A, Lash, T L, Cronin-Fenton, D P, Ulrichsen, S P, Christiansen, P M, Cole, B F, Tamimi, R M, Sørensen, H T & Damkier, P 2019, ' Phthalate exposure and breast cancer incidence : A danish nationwide cohort study ', Journal of Clinical Oncology, vol. 37, no. 21, pp. 1800-1809 . https://doi.org/10.1200/JCO.18.02202
PURPOSE Phthalate exposure is ubiquitous and especially high among users of drug products formulated with phthalates. Some phthalates mimic estradiol and may promote breast cancer. Existing epidemiologic studies on this topic are small, mostly not pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05a69c28eef6fc0dcb8e38280a949e8e
https://pure.au.dk/portal/da/publications/phthalate-exposure-and-breast-cancer-incidence(d060b0ed-1e04-41c0-bbc1-a4e733d2d5f7).html
https://pure.au.dk/portal/da/publications/phthalate-exposure-and-breast-cancer-incidence(d060b0ed-1e04-41c0-bbc1-a4e733d2d5f7).html
Autor:
Trine Tramm, Peer Christiansen, Anne Bodilsen, Hanne Melgaard Nielsen, Jonas Amstrup Funder, Anne Schmidt Sorensen, Marco Mele, Josephine Bruun
Publikováno v:
Mele, M, Sørensen, A S, Bruun, J, Funder, J A, Tramm, T, Bodilsen, A, Nielsen, H M & Christiansen, P M 2019, ' Inflammatory breast cancer : A review from our experience ', Breast Disease, vol. 38, no. 2, pp. 47-55 . https://doi.org/10.3233/BD-180365
INTRODUCTION: Inflammatory Breast Cancer (IBC) is a distinct and rare type of breast cancer accounting for up to 6% of all breast cancer cases in Europe. The aim of this study was to investigate diagnostic methods, treatments, and outcome after IBC i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c2fde238c6e05cc881054e1f438ab79
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
https://pure.au.dk/portal/da/publications/inflammatory-breast-cancer(c3af6599-1a4d-4e37-8e81-962726ba1a64).html
Autor:
Per Damkier, Thomas P. Ahern, Stephen Hamilton-Dutoit, Anders Kjærsgaard, Lindsay J Collin, Peer Christiansen, Kristina B. Christensen, Deirdre Cronin-Fenton, Kristina Lystlund Lauridsen, Timothy L. Lash, Henrik Toft Sørensen, Rami Yacoub
Publikováno v:
Collin, L J, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Damkier, P, Hamilton-Dutoit, S, Kjaersgaard, A, Lauridsen, K L, Yacoub, R, Christiansen, P, Sørensen, H T & Lash, T L 2019, ' Expression of survivin does not appear to influence breast cancer recurrence risk ', Acta Oncologica, vol. 58, no. 2, pp. 154-161 . https://doi.org/10.1080/0284186X.2018.1503419
BACKGROUND: Survivin is an inhibitor of apoptosis, and its expression associates with poor outcomes in multiple cancers. It may be a therapeutic target due to its unique expression in cancer cells.METHODS: We estimated the association between nuclear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11c5d4567c22bdcc224bb419fa7029e9
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
https://pure.au.dk/portal/da/publications/expression-of-survivin-does-not-appear-to-influence-breast-cancer-recurrence-risk(8edf1125-b428-4628-b8be-a770a766d5de).html
Autor:
Lida Pistioli, Peer Christiansen, Christos Markopoulos, Christina Hedin, Daniel Tegnelius, Nils Ryegaard Rasmussen, Leif Bergkvist, Malin Sund, Hjørdis Jørnsgård, Andreas Karakatsanis, Staffan Eriksson, Kosmas Daskalakis, Fredrik Wärnberg, Lone Fischer
Publikováno v:
Breast Cancer Research and Treatment
Karakatsanis, A, Christiansen, P M, Fischer, L, Hedin, C, Pistioli, L, Sund, M, Rasmussen, N R, Jørnsgård, H, Tegnelius, D, Eriksson, S, Daskalakis, K, Wärnberg, F, Markopoulos, C J & Bergkvist, L 2016, ' The Nordic SentiMag trial : a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies ', Breast Cancer Research and Treatment . https://doi.org/10.1007/s10549-016-3809-9
Karakatsanis, A, Christiansen, P M, Fischer, L, Hedin, C, Pistioli, L, Sund, M, Rasmussen, N R, Jørnsgård, H, Tegnelius, D, Eriksson, S, Daskalakis, K, Wärnberg, F, Markopoulos, C J & Bergkvist, L 2016, ' The Nordic SentiMag trial : a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies ', Breast Cancer Research and Treatment . https://doi.org/10.1007/s10549-016-3809-9
The aim of the study is to compare the efficacy of SPIO as a tracer in sentinel node biopsy (SNB) in breast cancer with Tc and patent blue in a multicentre prospective study and perform a meta-analysis of all published studies. It also aims to follow